Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2003
05/14/2003EP1309705A2 Multivalent target binding protein
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309703A2 Kallikrein gene
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309682A2 Tetraspan protein and uses thereof
05/14/2003EP1309679A2 Human genes and gene expression products
05/14/2003EP1309672A1 Method of producing infectious reovirus
05/14/2003EP1309627A1 Immunotherapy for chronic myelocytic leukemia
05/14/2003EP1309625A2 Therapeutic compounds for ovarian cancer
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309607A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309603A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof
05/14/2003EP1309597A2 Polymorphs of an epothilone analog
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309587A1 Cinnoline compounds
05/14/2003EP1309585A2 Novel indole derivatives and their use as medicaments
05/14/2003EP1309579A1 Inhibitors of matrix metalloproteinases
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309573A1 Urethane derivatives
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309569A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309568A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309567A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
05/14/2003EP1309373A2 Method and composition for altering a t cell mediated pathology
05/14/2003EP1309354A2 Therapeutic polyesters and polyamides
05/14/2003EP1309350A2 Chelerythrine-based therapies for cancer
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1309343A1 Vaccines against cytokines and growth factors derived from malignant tumours
05/14/2003EP1309338A1 Pharmaceutical composition comprising trkaig2 for use in the prevention and/or treatment of cancer
05/14/2003EP1309334A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/14/2003EP1309330A1 Photosensitizers with ligand targeting properties for tumor therapy
05/14/2003EP1309323A2 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1267940B1 Compounds for targeting
05/14/2003EP1200434B1 NEW CYTOTOXIC PYRIDO 2,3,4-kl]ACRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1140987B1 Peptides for inhibiting hpv e6 proteins
05/14/2003EP1140935B1 1,2-annelated quinoline derivatives
05/14/2003EP1102746B1 Substituted phenylamidines with antithrombotic action
05/14/2003EP1049463B1 Use of fc101 as an angiogenesis inhibitor for the treatment of cancer and other angiogenic diseases
05/14/2003EP1042317B1 Indole derivatives as PKC-inhiboitors
05/14/2003EP1029863B1 Camptothecin derivatives
05/14/2003EP0915872B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
05/14/2003EP0915869B1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/14/2003EP0814838B1 Antigen presenting system and activation of t-cells
05/14/2003EP0667772B1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
05/14/2003EP0666929B1 Method of inhibiting replication of hyperproliferative cells
05/14/2003CN1418256A Beta glucans from filamentous fungi
05/14/2003CN1418255A Herpes virus strains for gene therapy
05/14/2003CN1418254A Method for remodelling cell wall polysaccharide structures in plants
05/14/2003CN1418253A Proteins producing altered immunogenic response and methods of making and using the same
05/14/2003CN1418224A TCF responsive element
05/14/2003CN1418223A Novel human hepatoma associated protein and coding sequence thereof
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents
05/14/2003CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418190A N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
05/14/2003CN1418186A Novel crystal of stilbene derivative and process for producing the same
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418112A Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
05/14/2003CN1418111A Novel Ligands and method for preparing same
05/14/2003CN1418104A Cosmetic use of hop and ornithine
05/14/2003CN1418103A Polysaccharidic esters of N-derivatives of glutamic acid
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors
05/14/2003CN1417326A Latent-energy regeneration cell
05/14/2003CN1417229A Human tumor necrosin relative death inducing ligand mutein and its prepn process and medicine composition
05/14/2003CN1417228A Fluorescent phycocyanin and fluorescent phycoerythrin and their application
05/14/2003CN1417223A CR1 gene related to cell reconstitution, conduction and death
05/14/2003CN1417217A New oligosaccharides and its prepn
05/14/2003CN1417208A Prepn and application in preparing cancer-treating medicine of mistletoe alkaloid
05/14/2003CN1417198A Diterpene compound and its prepn and use
05/14/2003CN1417197A Diterpene compound and its prepn and use
05/14/2003CN1416903A Genetic medicine for treating cancer and other diseases characterized by run-off cell division and its prepn process
05/14/2003CN1416899A Prepn of cancer-treating medicine
05/14/2003CN1416897A Prepn process of expression library fusion vaccine
05/14/2003CN1416896A Tumor CT antigen immune inducing agent for treating liver cancer and its prepn
05/14/2003CN1416867A Effective cure made of natural plant material for treating AlDS, hepatitis B, hepatitis C and cancer
1 ... 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 ... 2211